Donate

News Archive

  • InterVac weathers market pressure and wins final approval

    Faced with unprecedented market escalation, the U of S board of governors has confirmed a revised $140-million final construction budget for the International Vaccine Centre, the largest investment to date in vaccine research in Canada.

  • Sod-Turning Celebration Launches U of S International Vaccine Centre

    Today representatives of all three levels of government and the Canada Foundation for Innovation turned the sod to launch construction of the International Vaccine Centre.

  • New Associate Director of Research Named

    We are pleased to announce that Dr. Volker Gerdts will become the new Associate Director of Research at the University of Saskatchewan’s VIDO/InterVac starting July 1.

  • Saskatoon is building success in vaccine research

    Bird flu has faded from the headlines, but delegates at May's World Health Assembly in Geneva say it remains the biggest health threat today. The University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) is taking it seriously, too.

  • New VIDO Director Named

    Andrew Potter, an internationally recognized authority on vaccine development, will become the new Director of the University of Saskatchewan’s Vaccine and Infectious Disease Organization.

  • Community Liaison Committee Launched for U of S InterVac

    The University of Saskatchewan has set up an independent Community Liaison Committee to ensure full and open communication on safety issues related to the International Vaccine Centre.

  • Colorado State University to confer honorary degree on VIDO director

    Colorado State University will confer an honorary doctoral degree on Dr. Lorne A. Babiuk at Spring 2007 commencement ceremonies.

  • Government of Saskatchewan commits $24.7 million to InterVac
  • VIDO Director accepts new position at University of Alberta

    Lorne Babiuk, director of the Vaccine and Infectious Disease Organization, has accepted the position of Vice-President Research at the University of Alberta.

  • Groundbreaking vaccine co-developed by U of S VIDO approved to protect water and food supply from E.coli O157:H7 contamination

    A groundbreaking vaccine for cattle that will protect water and food supplies from the toxic E. coli O157:H7 bacteria has been approved for release in Canada.